Drug Trial Radar · NCT04944706
Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
225
Actual
Start
Oct 18, 2021
Primary completion
Jan 22, 2025
Study completion Jan 22, 2025
Sponsor
- Lead sponsor
- Tasly Pharmaceutical Group Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Jun 30, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Main objective: To evaluate the efficacy, safety and clinical dose exploration of Qishen Yiqi dripping pills in the treatment of chronic heart failure with preserved ejection fraction.
Conditions
- Chronic Heart Failure With Preserved Ejection Fraction
Interventions
Qishen Yiqi dripping pills 2 bags/time + Qishen Yiqi dripping pills placebo 2 bags/timeDrug
Take 3 times a day after meals,24 weeks
Qishen Yiqi dripping pills 4 bags/timeDrug
Take 3 times a day after meals,24 weeks
Qishen Yiqi dripping pills placebo 4 bags/timeDrug
Take 3 times a day after meals,24 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- 6-Minutes-Walking-Test (6MWT)Time frame: Baseline to weeks 12 and 24
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
Beijing Hospital
Beijing, Beijing Municipality, China
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Xuanwu Hospital Capital Medical University
Beijing, Beijing Municipality, China
Peking University People's Hospital
Beijing, Bejing, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Hebei General Hospital
Shijiazhuang, Hebei, China
The Third Affiliated Hospital of Xinxiang Medical College
Xinxiang, Henan, China
The third Xiangya Hospital of Central South University
Changsha, Hunan, China
Jiangsu Province Hospital
Nanjing, Jiangsu, China
Zhongda Hospital Southeast University
Nanjing, Jiangsu, China
China Japan Union Hospital of Jilin University
Changchun, Jilin, China
The Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Nei Monggol Autonomous Region, China
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
The Second Affiliated Hospital Of Xi'an Jiaotong University
Xi’an, Shanxi, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.